Genetic Variants Associated with Increased Risk of Bipolar Disorder

New genetic research uncovers specific variants that significantly increase the risk of developing bipolar disorder, paving the way for personalized treatments and better understanding of the condition's genetic basis.
Recent research has advanced our understanding of the genetic factors contributing to bipolar disorder, a complex mental health condition characterized by extreme mood swings, including depressive and manic episodes. While previous genome-wide association studies (GWAS) identified numerous genomic regions linked to bipolar disorder, pinpointing the exact causal genetic variants remained a challenge. In a groundbreaking study published in Nature Neuroscience, scientists from the Icahn School of Medicine at Mount Sinai used refined fine-mapping techniques to identify specific single nucleotide polymorphisms (SNPs) that directly influence the disorder's risk.
The study analyzed genetic data from the Psychiatric Genomics Consortium (PGC), which includes thousands of individuals of European ancestry diagnosed with bipolar disorder and healthy controls. Applying advanced statistical methods and integrating epigenomic data related to brain cell types, the researchers narrowed down the genomic regions to 17 SNPs most likely involved in increasing bipolar disorder susceptibility.
Among the identified genetic variants, the team linked these SNPs to genes involved in brain development, neurocommunication, and synaptic signaling, such as SCN2A, TRANK1, CACNA1B, THSD7A, and FURIN. Notably, some of these genes also show high expression in gut cells, suggesting a potential connection between the microbiota–gut–brain axis and bipolar disorder.
This work enhances our understanding of the genetic architecture underlying bipolar disorder and offers promising avenues for future research. The integration of these genetic findings into polygenic risk scores improves prediction accuracy across diverse populations, bringing us closer to personalized healthcare approaches. Future studies aim to functionally validate these genetic variants using models like CRISPR-edited neuronal cells and brain organoids, ultimately paving the way for tailored therapeutic strategies based on individual genetic profiles.
This research marks a significant step forward in unraveling the complex genetic factors of bipolar disorder and highlights the importance of continued exploration into the genetic and biological underpinnings of psychiatric conditions.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Debunking the Risks of Mouth Taping During Sleep: What Science Says
Recent scientific reviews reveal that mouth taping during sleep offers limited benefits and poses significant safety risks, especially for individuals with nasal obstructions. Consult healthcare professionals for sleep issues.
Understanding and Addressing College Students' Misperceptions of Peer Alcohol Consumption
College students often overestimate peer alcohol consumption, leading to risky drinking behaviors. Protective strategies can help reduce negative outcomes. Learn more about the latest research and solutions.
Innovative High-Throughput Antibody Testing Platform to Accelerate Disease Research and Therapeutic Development
A new high-throughput antibody testing platform developed by University of Illinois researchers can rapidly generate and analyze large antibody libraries, accelerating disease research, vaccine development, and therapy discovery.
Innovative Approach to Slowing Glioblastoma Growth by Blocking Brain Damage
New research suggests that blocking brain damage caused by glioblastoma may slow tumor growth and preserve neurological function, opening new pathways for early intervention strategies.



